| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/09/2009 | US20090176003 Mutant delta-8 desaturase genes engineered by targeted mutagensis and their use in making polyunsaturated fatty acids |
| 07/09/2009 | US20090175983 Gene capable of improving low temperature fermentability and/or low temperature resistance and use thererof |
| 07/09/2009 | US20090175974 NOVEL CADHERIN RECEPTOR PEPTIDE FOR POTENTIATING Bt BIOPESTICIDES |
| 07/09/2009 | US20090175931 Compositions and methods for modulating hemostasis |
| 07/09/2009 | US20090175930 Composition Suppressing The Expression of Target Gene in Eyeball and Medicament For Treating of Disease in Eyeball |
| 07/09/2009 | US20090175923 Humanized anti-amyloid beta antibodies |
| 07/09/2009 | US20090175913 Ammendola/salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175907 Multi Plasmid System For The Production Of Influenza Virus |
| 07/09/2009 | US20090175904 Expressing hepatitis B virus surface antigen for vaccine preparation |
| 07/09/2009 | US20090175900 Methods for packaging propagation-defective vesicular stomatitis virus vectors |
| 07/09/2009 | US20090175899 Recombinant rsv virus expression systems and vaccines |
| 07/09/2009 | US20090175897 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175892 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| 07/09/2009 | US20090175889 Hiv vaccine |
| 07/09/2009 | US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders |
| 07/09/2009 | US20090175880 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 07/09/2009 | US20090175876 Methods of using phhla2 to co-stimulate t-cells |
| 07/09/2009 | US20090175874 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 07/09/2009 | US20090175872 Treatment of Conditions Involving Demyelination |
| 07/09/2009 | US20090175871 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 07/09/2009 | US20090175867 Single-Chain Multivalent Binding Proteins with Effector Function |
| 07/09/2009 | US20090175863 Agents targeting cd138 and uses thereof |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175847 Humanized antibodies to ab (20-42) globulomer and uses thereof |
| 07/09/2009 | US20090175844 Method of diagnosing bladder cancer |
| 07/09/2009 | US20090175839 Proteins with an attached short peptide of acidic amino acids |
| 07/09/2009 | US20090175830 Oncolytic adenovirus armed with therapeutic genes |
| 07/09/2009 | US20090175828 Coagulation Factor X Polypeptides With Modified Activation Properties |
| 07/09/2009 | US20090175826 Genetically-engineered newcastle disease virus as an oncolytic agent, and methods of using same |
| 07/09/2009 | US20090175825 Interferon alpha and antisense k-ras rna combination gene therapy |
| 07/09/2009 | US20090175796 Antibodies and related molecules that bind to 24p4c12 proteins |
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/09/2009 | US20090175790 Cardiac arrhythmia treatment methods and biological pacemaker |
| 07/09/2009 | US20090175789 Antibody raised against the ldl receptor |
| 07/09/2009 | US20090175784 Anti-Alpha V Immunoliposome Composition, Methods, and Uses |
| 07/09/2009 | US20090175529 Method and apparatus for selectively targeting specific cells within a cell population |
| 07/09/2009 | DE102008003028A1 Producing proteins with defined structures and functional properties in biological systems comprises controlled alternative splicing of gene sequences |
| 07/09/2009 | CA2744910A1 Replication-defective arenavirus vectors |
| 07/09/2009 | CA2711110A1 Methods and oligonucleotides for detection of mastitis causing bacteria |
| 07/09/2009 | CA2710812A1 Enzyme associated with equol synthesis |
| 07/09/2009 | CA2710760A1 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | CA2710713A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | CA2710549A1 Lignan hydroxylase |
| 07/09/2009 | CA2710543A1 Woody plants having improved growth charateristics and method for making the same using transcription factors |
| 07/09/2009 | CA2710388A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710387A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710382A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710380A1 Treatment of fibrotic conditions |
| 07/09/2009 | CA2710378A1 Engineered phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
| 07/09/2009 | CA2710375A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710359A1 Yeast organism producing isobutanol at a high yield |
| 07/09/2009 | CA2710232A1 Treatment of abnormal or excessive scars |
| 07/09/2009 | CA2710227A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710223A1 Treatment of surgical adhesions |
| 07/09/2009 | CA2710221A1 Drought tolerant plants and related constructs and methods involving genes encoding mir827 |
| 07/09/2009 | CA2710166A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 07/09/2009 | CA2709939A1 Engineered hybird phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
| 07/09/2009 | CA2709517A1 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 07/09/2009 | CA2709490A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | CA2709485A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | CA2709372A1 Ketol-acid reductoisomerase using nadh |
| 07/09/2009 | CA2709067A1 Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae |
| 07/09/2009 | CA2705925A1 Yeast strains for protein production |
| 07/08/2009 | EP2077334A1 Microorganism detection method and microorganism detection kit |
| 07/08/2009 | EP2077331A1 METHOD FOR EVALUATING COMPOUND USING PKC-iota |
| 07/08/2009 | EP2077330A1 Transgenic pig with altered incretin function and its uses for studying diabetes |
| 07/08/2009 | EP2077329A1 Transgenic pig with altered incretin function |
| 07/08/2009 | EP2077328A1 Platelet aggregation inhibitor composition |
| 07/08/2009 | EP2077327A1 Organ-specific gene, method for identifying the same and use thereof |
| 07/08/2009 | EP2077326A1 Novel nucleic acid |
| 07/08/2009 | EP2077325A1 Monoclonal antibody and use thereof |
| 07/08/2009 | EP2077324A2 Genes encoding proteolytic enzymes from aspargilli |
| 07/08/2009 | EP2077321A2 Mutant glucose dehydrogenase |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077278A1 Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| 07/08/2009 | EP2077276A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogensis |
| 07/08/2009 | EP2077275A2 IgA nephropathy-related DNA |
| 07/08/2009 | EP2077272A1 Polypeptide libraries with a predetermined scaffold |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/08/2009 | EP2076603A2 A serum-free virus propagation platform for a virus vaccine candidate |
| 07/08/2009 | EP2076602A2 Plant produtivity enhancement by combining chemical agents with transgenic modifications |
| 07/08/2009 | EP2076601A2 High yield production of sialic acid (neu5ac) by fermentation |
| 07/08/2009 | EP2076599A2 Mir-200 regulated genes and pathways as targets for therapeutic intervention |
| 07/08/2009 | EP2076598A2 Sirna and methods of manufacture |
| 07/08/2009 | EP2076597A2 Rna antagonist compounds for the modulation of pcsk9 |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076595A2 Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes |
| 07/08/2009 | EP2076593A1 Lipolytic enzyme variants |
| 07/08/2009 | EP2076591A2 Polyol oxidases |
| 07/08/2009 | EP2076587A2 Isolation, expansion and uses of tumor stem cells |
| 07/08/2009 | EP2076586A2 Recombinant hydrogen-producing cyanobacterium and uses thereof |
| 07/08/2009 | EP2076584A1 Genetic cluster of strains of streptococcus thermophilus having appropriate acidifying and texturizing properties for dairy fermentations |
| 07/08/2009 | EP2076542A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 07/08/2009 | EP2076539A2 Antibody molecules which bind il-17a and il-17f |
| 07/08/2009 | EP2076534A1 Peptides with high affinity for the prolactin receptor |
| 07/08/2009 | EP2076527A1 Processing enzymes fused to basic protein tags |